Lupin launches plaque psoriasis treatment spray in US market
Drug major Lupin today announced the launch of Desoximetasone Topical Spray, used for treatment of plaque psoriasis, in the US market.
Drug major Lupin today announced the launch of Desoximetasone Topical Spray, used for treatment of plaque psoriasis, in the US market.
"Lupin's Desoximetasone Topical Spray, 0.25 per cent, is the generic equivalent of Taro Pharmaceuticals U.S.A Inc.'s Topicort Topical Spray, 0.25 per cent. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older," the company said in a regulatory filing.
Quoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million in the US.
WATCH ZEE BUSINESS VIDEO HERE
Shares of Lupin were trading 0.71 per cent higher at Rs 820.35 apiece on BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Tata Motors Dividend 2024: Automaker's board recommend 300% dividend - Check payment date and other details
5 investment schemes that provide monthly pension to senior citizens fixed deposit fds savings scss guaranteed return atal pension yojana post office monthly income swps mutual fund
Akshaya Tritiya bank holiday or not Basava Jayanti 2024 festival date Banks closed or open tomorrow may 10 friday check out state-wise full list
01:12 PM IST